Growing Retinal Disorder Incidence Propels Macular Degeneration Treatment Market: Key Factor Driving The Growth In The Macular Degeneration Treatment Market

The Macular Degeneration Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Macular Degeneration Treatment Market Size and Its Estimated Growth Rate?
Recent years have witnessed significant growth in the macular degeneration treatment market. The market size is projected to increase from $11.05 billion in 2024 to $12.42 billion in 2025, with a compound annual growth rate (CAGR) of 12.4%. Factors such as an aging population, lifestyle modifications, limited therapy options, heightened awareness, and the advancement of healthcare infrastructure have contributed to the growth during the historic period.

In the coming years, the market for macular degeneration treatments is poised for substantial expansion, with projections stating it could reach a value of $19.06 billion by 2029. This would be a result of a Compound Annual Growth Rate (CAGR) of 11.3%. Several key factors could contribute to this predicted growth during the forecast period, including innovations in research, an increase in healthcare spending, escalating incidence rates, personalized medicinal strategies, and international endeavors to improve vision health. Other impactful trends expected during the forecast period include a shift towards neuroprotection and regeneration therapies, the broadening of telemedicine and remote patient monitoring, personalized medicinal strategies, stem cell therapy investigations, and patient-centric initiatives to raise awareness and educate.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5799

How Are Emerging Segments Shaping the Macular Degeneration Treatment Market Landscape?
The macular degeneration treatment market covered in this report is segmented -

1) By Stage of Disease: Early-Stage AMD, Intermediate AMD, Late-Stage AMD
2) By End User: Ambulatory Surgical Centers, Ophthalmic Clinics, Hospitals
3) By Route of Administration: Oral, Injectable, Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration

Subsegments:
1) By Early-Stage AMD: Nutritional Supplements, Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections, Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments, Advanced Anti-VEGF Therapies, Gene Therapy Options

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5799&type=smp

Which Growth Factors Are Influencing Macular Degeneration Treatment Market Expansion?
An escalation in retinal disorders is set to fuel expansion in the macular degeneration treatment market. These disorders impede the functional tissue needed for processing visual information, often resulting in distorted or non-existent vision. As an indication, the American Academy of Ophthalmology projects that by 2050, about 7.32 million Americans will be dealing with primary open-angle glaucoma. This term encompasses a range of eye conditions, with the vast majority being observed in populations aged between 70 and 79 years (32%), women (50%), and Hispanics (50%). The most significant demographic is Hispanic males. Hence, the rising prevalence of retinal disorders is propelling the growth of the market for macular degeneration treatments.

Who Are the Dominant Players Across Different Macular Degeneration Treatment Market Segments?
Major companies operating in the macular degeneration treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.

What Are the Latest Developing Trends in the Macular Degeneration Treatment Market?
The major players in the market for the treatment of macular degeneration are striving to develop biosimilars to enhance the availability of effective treatment for age-related macular degeneration (AMD). Biosimilars are biological medical products exhibiting high similarity to an already sanctioned reference product, possessing no significant differences regarding safety, purity, or efficacy. For example, in May 2024, FDA approvals were awarded to Biocon Biologics Ltd from India and Samsung Bioepis Co. Ltd from South Korea for their two new biosimilars, Yesafili and Opuviz. These biosimilars obstruct vascular endothelial growth factor (VEGF), which is culpable for unusual blood vessel development in the eye. This interference assists in preventing vision loss linked with ailments like AMD and diabetic retinopathy. The approval process of the FDA incorporated comparative researches affirming that Yesafili and Opuviz display no pronounced differences in safety or efficacy compared to Eylea. Such researches entailed intricate evaluations of the pharmacokinetics and immunogenicity of the biosimilars.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/macular-degeneration-treatment-global-market-report

Which Geographic Regions Are Expected to Dominate the Macular Degeneration Treatment Market in the Coming Years?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Macular Degeneration Treatment Market?
2. What is the CAGR expected in the Macular Degeneration Treatment Market?
3. What Are the Key Innovations Transforming the Macular Degeneration Treatment Industry?
4. Which Region Is Leading the Macular Degeneration Treatment Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.